Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis
Summary
Background Higher circulating levels of the branched-chain amino acids (BCAAs; i.e., isoleucine, leucine, and valine) are strongly associated with higher type 2 diabetes risk, but it is not known whether this association is causal. We undertook large-scale human genetic analyses to address this question. Methods and Findings Genome-wide studies of BCAA levels in 16,596 individuals revealed five genomic regions associated at genome-wide levels of significance (p < 5 × 10−8). The strongest signal was 21 kb upstream of the PPM1K gene (beta in standard deviations [SDs] of leucine per allele = 0.08, p = 3.9 × 10−25), encoding an activator of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) responsible for the rate-limiting step in BCAA catabolism. In another analysis, in up to 47,877 cases of type 2 diabetes and 267,694 controls, a genetically predicted difference of 1 SD in amino acid level was associated with an odds ratio for type 2 diabetes of 1.44 (95% CI 1.26–1.65, p = 9.5 × 10−8) for isoleucine, 1.85 (95% CI 1.41–2.42, p = 7.3 × 10−6) for leucine, and 1.54 (95% CI 1.28–1.84, p = 4.2 × 10−6) for valine. Estimates were highly consistent with those from prospective observational studies of the association between BCAA levels and incident type 2 diabetes in a meta-analysis of 1,992 cases and 4,319 non-cases. Metabolome-wide association analyses of BCAA-raising alleles revealed high specificity to the BCAA pathway and an accumulation of metabolites upstream of branched-chain alpha-ketoacid oxidation, consistent with reduced BCKD activity. Limitations of this study are that, while the association of genetic variants appeared highly specific, the possibility of pleiotropic associations cannot be entirely excluded. Similar to other complex phenotypes, genetic scores used in the study captured a limited proportion of the heritability in BCAA levels. Therefore, it is possible that only some of the mechanisms that increase BCAA levels or affect BCAA metabolism are implicated in type 2 diabetes. Conclusions Evidence from this large-scale human genetic and metabolomic study is consistent with a causal role of BCAA metabolism in the aetiology of type 2 diabetes.
Related articles
Dosage Calculations in Nursing
This document provides a comprehensive overview of dosage calculations in nursing, emphasizing the importance of precision in medication administration using various measurement systems, and highlighting common errors and guidelines for safe practice.
The Dynamic Nurse-Patient Relationship, Function, Process and Principles
This document discusses Ida Jean Pelletier's Deliberative Nursing Process Theory, emphasizing the interactive nature of nursing and the essential components involved in nurse-patient interactions. It outlines how critical thinking and reflective practice enhance patient care.
The Dynamic Nurse-Patient Relationship: Function, Process and Principles
This document discusses the Deliberative Nursing Process Theory conceptualized by Ida Jean Pelletier, highlighting its core principles and applications in nursing care. It emphasizes the dynamic interaction between nurses and patients and the importance of critical thinking in addressing patient needs.
The Roy Adaptation Model: A Comprehensive Nursing Framework
The Roy Adaptation Model is a nursing framework developed by Sister Callista Roy that emphasizes the person as a holistic adaptive system interacting with a changing environment, focusing on promoting adaptation to enhance health and quality of life.
The Life of Martha Rogers
Martha Rogers' Theory of Unitary Human Beings provides a revolutionary framework for nursing that emphasizes understanding humans as irreducible energy fields rather than merely treating symptoms. This theory integrates concepts from quantum physics and general system theory.